Issue link: http://digitalreprints.elsevier.com/i/111457

Contents of this Issue


Page 0 of 7

Reprinted from Blinded Comparator Study of Immunohistochemical Analysis versus a 92-Gene Cancer Classifier in the Diagnosis of the Primary Site in Metastatic Tumors Lawrence M. Weiss, Peiguo Chu, Brock E. Schroeder, Veena Singh, Yi Zhang, Mark G. Erlander, and Catherine A. Schnabel No responsibility is assumed by Elsevier, its licensors or associates for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. March 2013 – Volume 15, No. 2

Articles in this issue

view archives of ELS_BH86936_JMD - Weiss_500_0214